ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
67,542.84
0.07%
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs Yen
157.25
0.00%
Brent Oil
81.295
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Structure Therapeutics Inc (GPCR)

  7. Structure Therapeutics Inc (GPCR) ニュース

GPCR

Structure Therapeutics (GPCR)

Structure Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:GPCR
日付受信時刻ニュースソース見出しコード企業名
2024/05/1005 : 56Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GPCRStructure Therapeutics Inc
2024/05/1005 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
2024/05/1005 : 05GlobeNewswire Inc.Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
2024/03/0906 : 19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GPCRStructure Therapeutics Inc
2024/03/0906 : 05GlobeNewswire Inc.Structure Therapeutics to Present at Leerink Partners Global Biopharma ConferenceNASDAQ:GPCRStructure Therapeutics Inc
2024/03/0823 : 19Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GPCRStructure Therapeutics Inc
2024/03/0822 : 43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
2024/03/0822 : 30GlobeNewswire Inc.Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
2023/12/1822 : 28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
2023/12/1821 : 30GlobeNewswire Inc.Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical StudyNASDAQ:GPCRStructure Therapeutics Inc
2023/11/3014 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GPCRStructure Therapeutics Inc
2023/11/1807 : 25Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GPCRStructure Therapeutics Inc
2023/11/1806 : 55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GPCRStructure Therapeutics Inc
2023/11/1806 : 51Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:GPCRStructure Therapeutics Inc
2023/11/1707 : 13Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:GPCRStructure Therapeutics Inc
2023/11/1506 : 10GlobeNewswire Inc.Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
2023/09/2920 : 50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
2023/09/2920 : 38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
2023/09/2920 : 32GlobeNewswire Inc.Structure Therapeutics Announces $300 Million Private Placement Equity FinancingNASDAQ:GPCRStructure Therapeutics Inc
2023/09/2920 : 30GlobeNewswire Inc.Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program UpdateNASDAQ:GPCRStructure Therapeutics Inc
2023/08/1105 : 41Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GPCRStructure Therapeutics Inc
2023/08/1105 : 19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
2023/08/1105 : 05GlobeNewswire Inc.Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
2023/08/0505 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
2023/08/0406 : 32GlobeNewswire Inc.Structure Therapeutics Appoints Ted W. Love, M.D., to Board of DirectorsNASDAQ:GPCRStructure Therapeutics Inc
2023/07/0705 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
2023/06/0721 : 30GlobeNewswire Inc.Structure Therapeutics Announces Poster Presentations of its Oral GLP-1 Receptor Agonist GSBR-1290 at the American Diabetes Association 83rd Scientific SessionsNASDAQ:GPCRStructure Therapeutics Inc
2023/06/0605 : 06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GPCRStructure Therapeutics Inc
2023/06/0105 : 30GlobeNewswire Inc.Structure Therapeutics to Present at Jefferies Healthcare ConferenceNASDAQ:GPCRStructure Therapeutics Inc
2023/05/2605 : 30GlobeNewswire Inc.Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and ObesityNASDAQ:GPCRStructure Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:GPCR

最近閲覧した銘柄

NYSE
BAC
Bank of America
NYSE
JPM
JP Morgan Chase
NASDAQ
MSFT
Microsoft
SPI
SP500
S&P 500
NYSE
NKE
Nike
NYSE
CVX
Chevron
NASDAQ
NVDA
NVIDIA
NYSE
XOM
Exxon Mobil
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USI
USTECH100
US Tech 100
NYSE
DIS
Walt Disney
USOTC
BASFY
BASF (QX)
CCOM
US500
US 500
NASDAQ
AMZN
Amazon.com
NASDAQ
AAPL
Apple
CCOM
SILVER
SILVER
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有